mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.07 |
mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.07 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.07 |
mRNA |
Sorafenib |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.07 |
mRNA |
silmitasertib |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.07 |
mRNA |
BRD-K20514654 |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.07 |
mRNA |
Doxorubicin |
FIMM |
pan-cancer |
AAC |
-0.26 |
0.07 |
mRNA |
THZ-2-102-1 |
GDSC1000 |
pan-cancer |
AAC |
0.059 |
0.07 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.07 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.07 |